Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Jean Brown Research Announces Participation in a Phase II/III Clinical Trial of Investigational Vaccine Used to Prevent Infection in Cardiothoracic Surgery Patients
Jean Brown Research Announces Its Participation in a Phase II/III Clinical Trial of an Investigational Vaccine Used to Prevent Staphylococcus Aureus Infection in Patients Undergoing Cardiothoracic Surgery. - May 19, 2010 - Jean Brown Research
Voicebrook to Exhibit at 2010 PowerPath® Users Conference
Company to demonstrate industry-leading solutions at Impac’s 2010 Annual Users Group Meeting in Amelia Island, Florida - May 19, 2010 - Voicebrook, Inc.
VIRUN® to Premiere OmegaH2O® Through WEDAR at CPhI and HI/NI in Shanghai, China
Virun to premiere water soluble and shelf stable OmegaH2O® in China through WEDAR Biotechnology Co. Ltd. OmegaH2O® is patents pending. - May 18, 2010 - VIRUN
Statistics Confirm That Botox Training Spells Success for Capturing Minimally-Invasive Market
The International Association for Physicians In Aesthetic Medicine (IAPAM) offers the industry's leading hCG for weight loss, aesthetic medicine and Botox training for physicians. The IAPAM's Aesthetic Medicine Symposium offers the most comprehensive clinical and business training for doctors looking to add minimally-invasive procedures to a healthcare business. The IAPAM's training focuses on combining the top-5 non-invasive procedures in order to create a successful aesthetic practice. - May 12, 2010 - International Association for Physicians in Aesthetic Medicine
New Brigham and Women’s Hospital Report Brings Lung Cancer in Women Out of the Shadows
BWH releases the most current and comprehensive overview of the impact of lung cancer on women. - May 12, 2010 - Brigham and Women’s Hospital
World of Lupus Research Expands as Florida Joins the Lupus Research Institute's National Coalition
Addition of State of Florida on World Lupus Day 2010 Pumps Extra Strength into Patient’s Voice for Lupus Research - May 11, 2010 - Lupus Research Institute
Cepoint Launches HD-SDI Multiple Channel DVR with IRIG-B or GPS Frame-Time Stamp
Cepoint Networks, LLC launched its RGB(HDTV) and HD-SDI Multi-channel version of its HD Studio9000 Digital Video Recorder system with IRIG-B or GPS frame time-stamp capability. Model ST9000HDSD which is designed for High definition Broadcast and Surveillance video capturing and recording applications conforms to SMPTE 292 standard and has capability of simultaneous audio capture and recording. - May 11, 2010 - CePOINT Networks, LLC
Clinical Trial Compares Leading-Edge Treatments for Obesity and Diabetes
New Research Will Look at Weight Loss Stomach Surgery Versus Intensive Program of Lifestyle and Medical Management. - May 10, 2010 - Brigham and Women’s Hospital
HealthSaaS, Inc. Releasing Online Vertical Suite of Condition and Disease Specific Personal Health Records (PHR)
HealthSaaS today announced they are releasing an online suite of condition and disease specific Personal Health Record (PHR) services. The first to be released is PainPHR http://www.painPHR.com DiabetesPHR and SportsmedPHR will be available later this year. BreastcancerPHR and ProstatecancerPHR... - May 07, 2010 - HealthSaaS, Inc
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010 - RayBiotech, Inc
National Patient Safety Foundation Awards Grant to Research Safety of Computerized Ordering of Medications
Quantros MEDMARX medication error reporting system will be linchpin of new patient safety research project. - April 29, 2010 - Quantros Inc.
Lupus Research Institute: News on Possible Drug for Lupus—Benlysta™
Human Genome Sciences (HGS) and GlaxoSmithKline Report Topline Results of 76-Week, Phase 3 Study - April 22, 2010 - Lupus Research Institute
Clinical Research Coordinators Create Niche Business Offering Clinical Research Expertise to Private Medical Practices in Florida
Clinical Research Coordinators Deborah Eyerdam and Diane Paquet, both of South Florida, have partnered to create Certified Clinical Research Coordinators of Florida, a private company that will provide training and temporary staffing for MDs looking to expand their businesses and add a new income... - April 17, 2010 - Certified Clinical Research Coordinators of Florida
Landmark Lung Cancer Research Study Approves Only Site in Colorado
Denver CyberKnife obtains IRB approval as the only site in Colorado to participate in a phase IIII lung cancer trial comparing radiosurgery to surgery. - April 16, 2010 - Denver CyberKnife
Official Patent Approval for the "actiCAP" EEG Cap Approaches
The “actiCAP” active electrode system is to be officially recognized as an innovation with a US patent - April 16, 2010 - Brain Products GmbH
Vitamin D May Protect from Cardiovascular Events
Researchers stress importance of large scale clinical trials to confirm the role of both vitamin D and calcium in the prevention of cardiovascular disease. - April 16, 2010 - Brigham and Women’s Hospital
Eden Spine Receives New Patent for Its Corpectomy Device, the GIZA™
Eden Spine, a Florida based Medical Devices organization focused on developing the latest generation of spinal technologies, is pleased to announce that the Patent for its corpectomy device, the GIZA™, was granted from the European Patent Office. “The GIZA™ allows Eden to provide... - March 26, 2010 - Eden Spine, LLC
International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment from Human Parthenogenetic Stem Cells
International Stem Cell Corporation, an international pioneer and leader in stem cell research, begins its second pre-clinical phase of testing retinal pigment epithelium (RPE) derived from human parthenogenetic stem cells for the treatment of retinal diseases. - March 24, 2010 - International Stem Cell Corporation
Female Hot Flash Research Study Continues
Avail Clinical Research conducting research studies on post menopausal women for hot flash treatments. - March 24, 2010 - Avail Clinical Research
U.S. Patent Granted for the Multimeric Adiponectin ELISA
A United States patent has been granted to Sekisui Medical Corp. (Tokyo, Japan), the inventors of the Multimeric Adiponectin ELISA. The Multimeric Adiponectin ELISA is distributed in the U.S. and Canada exclusively by ALPCO Diagnostics. - March 23, 2010 - ALPCO
Avail Clinical Research Announces Osteoarthritis Research Studies in DeLand, FL
Avail Clinical Research Announces Osteoarthritis Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 23, 2010 - Avail Clinical Research
Study Finds Many New Prescriptions Go Unfilled
Potential health benefits are not being realized because more than a quarter of new prescriptions are never filled. - March 14, 2010 - Brigham and Women’s Hospital
Researchers Identify Genetic Pathway Responsible for Metastatic Prostate Cancer
Four genes identified that are together a pathway responsible for driving metastatic prostate cancer. - March 14, 2010 - Brigham and Women’s Hospital
Avail Clinical Research Announces High Cholesterol Research Studies in DeLand, FL
Avail Clinical Research Announces High Cholesterol Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 12, 2010 - Avail Clinical Research
Avail Clinical Research Announces High Blood Pressure (Hypertension) Research Studies in DeLand, FL
Avail Clinical Research Announces High Blood Pressure (Hypertension) Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 10, 2010 - Avail Clinical Research
Bio-Synthesis Awarded NIH Grant to Develop Synergistic Adjuvants that Stimulate both Innate and Adaptive Immunities
BioSynthesis announces the award of a two-year phase I SBIR grant by NIH to further its development program of immune agonists. These new agents have in their chemical structure different determinants that stimulate both innate and acquired immunity, leading to synergistic effects on the immune response. These new immune agonists could be useful in the development of difficult vaccines such as HIV-1 and cancer vaccines. - March 09, 2010 - Bio-Synthesis Inc.
Pharmacodiagnostics and Personalized Medicine 2009 Markets, Challenges, Forecasts and Key Players Reports Now Available on ReportsandReports
Personalized Medicine has given the diagnostics field a huge boost in terms of publicity/public attention, revenue potential, and investment interest. Still questions exist as to how extensive such testing will be and how soon we will see its growth in clinical applications. - March 06, 2010 - marketsandmarkets
AVT-12 Weight Loss Drug Product Study Concludes
The weight loss combination drug product, AVT-12 has most recently been the subject of a year-long phase III randomized, double-blind, placebo-controlled efficacy trial, conducted by ITCES Corporation. - March 05, 2010 - ITCES Corporation
Avail Clinical Research Announces Hepatitis C Research Studies in DeLand, FL
Avail Clinical Research Announces Hepatitis Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 05, 2010 - Avail Clinical Research
ComFit Solution’s WAVE Vibration Therapy Study Shows Improvement in Strength and Motor Skills in Multiple Sclerosis Patients
A two-month vibration therapy study in Omaha with 70 Multiple Sclerosis (MS) patients has shown remarkable results. WAVE (Whole-body Advanced Vibration Exercise) technology has improved the patient‟s motor skills, decreased spasticity and increased flexibility. For the study, the training... - March 05, 2010 - ComFit Solutions, LLC
ICTS Provides Solutions for Rheumatology Study
Tom Sturgis, president of ICTS (Integrated Clinical Trial Services, LLC) (www.icts.us), has announced that the company has completed the development and implementation of a program designed to increase patient consent in a rheumatology study. The ongoing and parallel studies showed a low consent... - March 04, 2010 - Integrated Clinical Trial Services
Avail Clinical Research Announces Gout Research Studies in DeLand, FL
Avail Clinical Research Announces Gout Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida - March 03, 2010 - Avail Clinical Research
March is Endometriosis Awareness Month
Backed by Congressional legislation, the Endometriosis Research Center is again celebrating March as “Endometriosis Awareness Month” in honor of all those affected by the disease. Endometriosis is a painful reproductive and immunological disease in which tissue similar to the uterine... - March 02, 2010 - Endometriosis Research Center
Avail Clinical Research Announces Gastroesophageal Reflux Disease Research Studies in DeLand, FL
Avail Clinical Research Announces Gastroesophageal Reflux Disease Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida - February 26, 2010 - Avail Clinical Research
Avail Clinical Research Announces Fibromyalgia Research Studies in DeLand, FL
Avail Clinical Research announces the launch of several research studies to test investigational treatment options for those already diagnosed with fibromyalgia. - February 24, 2010 - Avail Clinical Research
Speed New Drug and Medical Device Time to Market with Advice in New Book by Cerulean's Managing Director
FDA compliance guru, John Avellanet, shows biopharmaceutical and device executives how to speed time to market with new medicines and turn regulatory compliance into a competitive business advantage in his new book, Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine. - February 19, 2010 - Cerulean Associates LLC
Avail Clinical Research Announces Diabetes Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida
Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, FL, announces the launch of several research studies to test investigational treatment options for those already diagnosed with diabetes. “We are very pleased to begin the systemic evaluation of our... - February 17, 2010 - Avail Clinical Research
SNUS and Tobacco Research Study; Avail Clinical Research
Avail Clinical Research, announced the beginning of a clinical research study for people who regularly consume tobacco products such as: SNUS, snuff, chewing tobacco, dip, and other oral tobaccos. - February 07, 2010 - Avail Clinical Research
Lupus Research Institute Invites Scientists with Innovative Ideas to Help Pioneer Lupus Discovery
The world’s leading private supporter of innovative research in systemic lupus erythematosus (lupus)—the Lupus Research Institute (LRI)—invites scientists with bold new approaches to discovering the cause, improving treatment, and curing lupus to apply for financial support. - February 05, 2010 - Lupus Research Institute
International Medical Association Publishes Guidelines for Tracking Safety of Adult Stem Cell Procedures
International medical association publishes landmark best practices guidelines that define the methodology for tracking patient safety and outcomes after stem cell treatments. - February 05, 2010 - International Cellular Medicine Society
Noesys Data Adds Seasoned Industry Veteran to Bolster Sales
Noesys Data announced today that Thomas Bennett, a 15 year veteran in physiological data collection and analysis market, has joined its team to deliver its unique solutions to the scientific research community. - February 03, 2010 - Noesys Data
Biomarker Discovery Grant Deadline Extended
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business Development for RayBiotech, Inc. - February 02, 2010 - RayBiotech, Inc
Avail Clinical Research Announces Irritable Bowel Syndrome Research Studies in DeLand, FL
Irritable Bowel Syndrome research studies for those already diagnosed with IBS being conducted in DeLand, FL. - January 27, 2010 - Avail Clinical Research
AncestrybyDNA Reveals Secrets of Past Heritage
DNA Diagnostics Centre UK has launched AncestrybyDNA™, a unique DNA test that reveals a person's ancestral origins. - January 26, 2010 - DNA Diagnostics Centre
Researchers Study Gene Critical in Animal Development
Biomedical researchers at the NC State University College of Veterinary Medicine using fluorescent zebrafish embryos to study gene responsible for animal growth, cancer formation. - January 24, 2010 - North Carolina State Univeristy College of Veterinary Medicine
Flexfit Announces Successful 2009 Sponsorship of Mauli Ola Foundation’s Surf Experience Days to Benefit Kids with Cystic Fibrosis
Flexfit is grateful to Mauli Ola Foundation for the opportunity to have sponsored their 2009 Surf Experience Days, which helped spread awareness of Cystic Fibrosis. - January 11, 2010 - Flexfit
Researchers Develop First Successful Hair Cloning Technique - A Major Advancement in Hair Restoration
Gary Hitzig, M.D., a New York hair transplant surgeon and researcher and Jerry Cooley, M.D., a Charlotte dermatologist and researcher, are the first medical doctors to successfully develop a hair cloning technique using an FDA-cleared wound healing powder. - January 08, 2010 - Gary Hitzig, M.D.
Two Long-Established Independent IRBs Discussing Merger
Two Independent Review Boards, responsible for the review of human subject research are discussing a merger to utilize their combined 46 years of experience to create a new Limited Liability Corporation. - January 07, 2010 - Ethical and Independent Review Services
Founder of Macular Degeneration Foundation Dies at 94
After dedicating his life to public awareness of ARMD (Age-Related Macular Degeneration, Edmund J. Aleksandrovich (Ed Aleks) dies at the age of 94. - December 22, 2009 - Macular Degeneration Foundation
Medical Society Announces Publication of Largest Stem Cell Safety Study to Date
The ICMS announces the publication of the largest stem cell safety study. Using the guidelines put forward by the ICMS, 227 patients were followed for complications after receiving adult stem cell therapies using a novel new protocol. No serious complications were reported. - December 19, 2009 - International Cellular Medicine Society